You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plerixafor

Showing 1 - 25 of 182
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

Active, not recruiting
  • Relapsed Adult ALL
  • Relapsed Adult AML
  • Plerixafor
  • Changchun, Jilin, China
    First Hospital of Jilin University
Nov 19, 2023

Sickle Cell Disease Trial in Memphis (Plerixafor)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 11, 2023

Lymphoma Trial in Beijing (Plerixafor,G-CSF)

Not yet recruiting
  • Lymphoma
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Aug 19, 2022

Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)

Completed
Has Results
  • Multiple Myeloma
  • Stanford, California
    Stanford University
Aug 17, 2022

Sickle Cell Disease Trial in Boston, Memphis (MGTA-145, Plerixafor)

Recruiting
  • Sickle Cell Disease
  • MGTA-145
  • Plerixafor
  • Bethesda, Maryland
  • +2 more
Nov 4, 2022

Autologous Haematopoietic Stem Cell Transplant Trial in China (plerixafor + G-CSF)

Recruiting
  • Autologous Haematopoietic Stem Cell Transplant
  • plerixafor + G-CSF
  • China, China
    Investigational Sites
May 4, 2022

Sickle Cell Disease Trial in Duarte (Plerixafor)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Sickle Cell Disease Trial in New York (Plerixafor)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • New York, New York
  • +1 more
Mar 21, 2022

Chronic Granulomatous Disease X-linked (X-CGD) Trial in Rome, Milan (Ibuprofen, Myelostim, Mozobil)

Recruiting
  • Chronic Granulomatous Disease X-linked (X-CGD)
  • Rome, Lazio, Italy
  • +1 more
Oct 27, 2022

COVID-19 Acute Respiratory Distress Syndrome, COVID-19 Trial in Bulgaria, France (Plerixafor 20 MG/ML [Mozobil], Placebo)

Active, not recruiting
  • COVID-19 Acute Respiratory Distress Syndrome
  • COVID-19
  • Plerixafor 20 MG/ML [Mozobil]
  • Placebo
  • Haskovo, Bulgaria
  • +13 more
Nov 8, 2022

Fanconi Anemia Trial in Paris (G-CSF, Plerixafor)

Completed
  • Fanconi Anemia
  • Paris, France
    Hôpital necker-Enfants malades
Dec 20, 2021

Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

Terminated
  • Related Donors Donating PBSC to a Family Member
  • +4 more
  • MGTA-145
  • Plerixafor
  • Duarte, California
  • +7 more
Apr 13, 2022

Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
  • Idiopathic CD4-Positive
  • T-Lymphocytopenia
  • Filgrastim
  • Plerixafor
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Asherman Syndrome, Atrophic Endometrium, Recurrent Implantation Failure Trial in Orange (Plerixafor)

Not yet recruiting
  • Asherman Syndrome
  • +2 more
  • Plerixafor
  • Orange, Connecticut
    Yale Fertility Center
Jul 13, 2022

Sickle Cell Anemia, Beta Thalassemia Trial run by the NHLBI (radiation, drug, biological)

Recruiting
  • Sickle Cell Anemia
  • Beta Thalassemia
  • TBI
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)

Completed
  • Non-Hodgkin's Lymphoma
  • Plasma Cell Myeloma
  • Hematopoietic Cell Transplantation
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022

Healthy Volunteers Trial in Cincinnati (MGTA-145, plerixafor, Placebo)

Completed
  • Healthy Volunteers
  • MGTA-145
  • +2 more
  • Cincinnati, Ohio
    Medpace CPU
Feb 24, 2021

T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

Terminated
Has Results
  • T-cell Non-Hodgkin Lymphoma
  • Boston, Massachusetts
  • +1 more
Jan 26, 2023

Sickle Cell Disease Trial in Memphis (hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and

Recruiting
  • Sickle Cell Disease
  • hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus
  • hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
May 5, 2022

Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Active, not recruiting
  • Multiple Myeloma
  • Plerixafor
  • Torino, Italy
    A.O.U. Città della Salute e della Scienza di Torino
Aug 17, 2021

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting
  • HIV
  • Hematologic Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Healthy Trial run by the NHLBI (AMD 3100 (Mozobil plerixafor), Granulocyte colony-stimulating factor (G-CSF))

Completed
Has Results
  • Healthy
  • AMD 3100 (Mozobil plerixafor)
  • Granulocyte colony-stimulating factor (G-CSF)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2021

Multiple Myeloma and Malignant Lymphoma Trial in Japan (KRN125(pegfilgrastim), PLR001(plerixafor), KRN8601(filgrastim),

Recruiting
  • Multiple Myeloma and Malignant Lymphoma
  • KRN125(pegfilgrastim), PLR001(plerixafor)
  • KRN8601(filgrastim), PLR001(plerixafor)
  • Nagoya, Aichi, Japan
  • +20 more
May 20, 2022

Sickle Cell Disease Trial in United States (biological, drug, genetic)

Recruiting
  • Sickle Cell Disease
  • Plerixafor
  • +2 more
  • Oakland, California
  • +5 more
Sep 13, 2022

Myeloma Trial in Chicago (drug, procedure, device)

Active, not recruiting
  • Myeloma
  • Chicago, Illinois
    University of Chicago
Sep 14, 2021